We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Nano-tech Diagnostic Can Indicate Cancer or Thrombotic Risk in One Drop of Blood

News   Jul 20, 2018 | Original story from Trinity College Dublin

 
Nano-tech Diagnostic Can Indicate Cancer or Thrombotic Risk in One Drop of Blood

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Exome Sequencing May Fall Short As Standalone Tool for Newborn Screening

News

Scientists from UC San Francisco, UC Berkeley and Tata Consultancy Services are offering the first comprehensive assessment of how sequencing stacks up to the older screening technology, tandem mass spectrometry (MS/MS), that California uses to analyze the blood spots taken at birth for rare disorders, known as inborn errors of metabolism.

READ MORE

Team Determines Dose Threshold That Increases Delivery of Anticancer Drugs

News

A team of researchers has discovered a dose threshold that greatly increases the delivery of cancer-fighting nanoparticle drugs into a tumor.

READ MORE

Mass Spectrometry Shows Potential for Rapid SARS-CoV-2 Detection

News

Signature peptides of the SARS-CoV-2 virus in clinical samples (nasopharyngeal swabs) have been detected by mass spectrometry in 3 minutes and without specific reagents. It provides a proof of concept of the use of this method as a possible alternative to PCR, currently the reference method.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE